Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen other Products (Segment Note 2 Aggregate) — U.S. product sales ($M) ($M)
Form 10-Q / 10-K Note 2 & MD&A Other Product Sales by Geographic Region
Latest, FY2025
5,437
Period ended Dec 31, 2025
Change on a year earlier
+34.7%
4,037 in FY2024
History
13 years
Since FY2013
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Products (Segment Note 2 Aggregate) — U.S. product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,437 | +34.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 4,037 | +22.1% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 3,307 | -8.3% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 3,606 | -14.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 4,194 | +15.5% | Form 10-K (filed 2024-02-14) ↗ |
| FY2020 | Dec 31, 2020 | 3,630 | +19.8% | Form 10-K (filed 2023-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 3,031 | -24.9% | Form 10-K (filed 2022-02-16) ↗ |
| FY2018 | Dec 31, 2018 | 4,035 | +103.7% | Form 10-K (filed 2021-02-09) ↗ |
| FY2017 | Dec 31, 2017 | 1,981 | +3.6% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 1,913 | +78.5% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 1,072 | +45.5% | Form 10-K (amgn-12312015x10k.htm, filed 2016-02-16) ↗ |
| FY2014 | Dec 31, 2014 | 737 | +68.3% | Form 10-K (amgn-12312015x10k.htm, filed 2016-02-16) ↗ |
| FY2013 | Dec 31, 2013 | 438 | – | Form 10-K (amgn-12312015x10k.htm, filed 2016-02-16) ↗ |
Cite this data
StockData. (2026). Amgen Other Products (Segment Note 2 Aggregate) — U.S. product sales ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod_other_us
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.